Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5081126
Max Phase: Preclinical
Molecular Formula: C15H9FN4
Molecular Weight: 264.26
Molecule Type: Unknown
Associated Items:
ID: ALA5081126
Max Phase: Preclinical
Molecular Formula: C15H9FN4
Molecular Weight: 264.26
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Fc1cc(-c2cnc3c(c2)[nH]c2ncccc23)ccn1
Standard InChI: InChI=1S/C15H9FN4/c16-13-7-9(3-5-17-13)10-6-12-14(19-8-10)11-2-1-4-18-15(11)20-12/h1-8H,(H,18,20)
Standard InChI Key: ADKKJWNYETZRMA-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 264.26 | Molecular Weight (Monoisotopic): 264.0811 | AlogP: 3.31 | #Rotatable Bonds: 1 |
Polar Surface Area: 54.46 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.28 | CX Basic pKa: 2.51 | CX LogP: 2.38 | CX LogD: 2.37 |
Aromatic Rings: 4 | Heavy Atoms: 20 | QED Weighted: 0.54 | Np Likeness Score: -1.04 |
1. Kroth H, Oden F, Serra AM, Molette J, Mueller A, Berndt M, Capotosti F, Gabellieri E, Schmitt-Willich H, Hickman D, Pfeifer A, Dinkelborg L, Stephens A.. (2021) Structure-activity relationship around PI-2620 highlights the importance of the nitrogen atom position in the tricyclic core., 52 [PMID:34839158] [10.1016/j.bmc.2021.116528] |
Source(1):